IP Library Granted Patent US 10,800,829
Granted Patent B2
US 10,800,829 · App. 16/654,147 · Granted Oct 13, 2020

Optogenetic probes for measuring membrane potential

Inventors: Adam Ezra Cohen (Cambridge, MA); Daniel Hochbaum (Cambridge, MA); Peng Zou (Cambridge, MA); Samouil Leon Farhi (Cambridge, MA); Robert Earl Campbell (Edmonton, CA); Yongxin Zhao (Edmonton, CA); Daniel Jed Harrison (Edmonton, CA)
Assignees: President and Fellows of Harvard College; The Governors of the University of Alberta
C07K14/705C07K14/215G01N21/6428G01N33/566G01N2021/6441G01N2333/726
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,800,829
App. No.
16/654,147
Granted
Oct 13, 2020
Kind
B2
Abstract

Provided herein are variants of an archaerhodopsin useful for application such as optical measurement of membrane potential. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, cells comprising the polynucleotides, and cells comprising the polypeptides; and methods of using the variants.

Claims (35)

1. A polypeptide comprising: a sequence of a modified microbial rhodopsin having at least 90% sequence identity to SEQ ID NO: 1; with one or more conservative substitutions comprising at least,

a first substitution at a position selected from the group consisting of D95 and D106; and

a second substitution at a position selected from the group consisting of P60, T80 and F161.

2. The polypeptide of claim 1 , wherein the one or more conservative substitutions is an amino acid substitution that maintains a structure of a backbone of the modified microbial rhodopsin.

3. The polypeptide of claim 1 , wherein the one or more conservative substitutions is an amino acid substitution that maintains the hydrophobicity of the sequence.

4. The polypeptide of claim 1 , wherein the one or more conservative substitutions is one of the following:

an alanine (A) substituted with an amino acid selected from the group consisting of D-ala, Gly, Aib, β-Ala, Acp, L-Cys and D-Cys;

an arginine (R) substituted with an amino acid selected from the group consisting of D-Arg, Lys, D-Lys, homo-Arg, D-homo-Arg, Met, Ile, D-Met, D-Ile, Orn and D-Orn;

an asparagine (N) substituted with an amino acid selected from the group consisting of D-Asn, Asp, D-Asp, Glu, D-Glu, Gln and D-Gln;

an aspartic acid (D) substituted with an amino acid selected from the group consisting of D-Asp, D-Asn, Asn, Glu, D-Glu, Gln and D-Gln;

a cysteine (C) substituted with an amino acid selected from the group consisting of D-Cys, S-Me-Cys, Met, D-Met, Thr and D-Thr;

a glutamine (Q) substituted with an amino acid selected from the group consisting of D-Gln, Asn, D-Asn, Glu, D-Glu, Asp and D-Asp;

a glutamic acid (E) substituted with an amino acid selected from the Group consisting D-Glu, D-Asp, Asp, Asn, D-Asn, Gln and D-Gln;

a glycine (G) substituted with an amino acid selected from the group consisting of Ala, D-Ala, Pro, D-Pro, Aib, β-Ala and Acp;

an isoleucine (I) substituted with an amino acid selected from the group consisting of D-Ile, Val, D-Val, AdaA, AdaG, Leu, D-Leu, Met and D-Met;

a leucine (L) substituted with an amino acid selected from the group consisting of D-Leu, Val, D-Val, AdaA, AdaG, Leu, D-Leu, Met and D-Met;

a lysine (K) substituted with an amino acid selected from the group consisting of D-Lys, Arg, D-Arg, homo-Arg, D-homo-Arg, Met, D-Met, Ile, D-Ile, Orn and D-Orn;

a methionine (M) substituted with an amino acid selected from the group consisting of D-Met, S-Me-Cys, Ile, D-Ile, Leu, D-Leu, Val and D-Val;

a phenylalanine (F) substituted with an amino acid selected from the group consisting of D-Phe, Tyr, D-Thr, L-Dopa, His, D-His, Trp, D-Trp, Trans-3,4 or 5-phenylproline, AdaA, AdaG, cis-3,4 or 5-phenylproline, Bpa and D-Boa;

a proline (P) substituted with an amino acid selected from the group consisting of D-Pro, L-I-thioazolidine-4-carboxylic acid and D-or-L-1-oxazolidine-4-carboxylic acid;

a serine (S) substituted with an amino acid selected from the group consisting of D-Ser, Thr, D-Thr, alto-Thr, Met, D-Met, Met (O), D-Met (O), L-Cys and D-Cys:

a threonine (T) substituted with an amino acid selected from the group consisting of D-Thr, Ser, D-Ser, allo-Thr, Met, D-Met, Met (O), D-Met (O), Val and D-Val;

a tyrosine (Y) substituted with an amino acid selected from the group consisting of D-Tyr, Phe, D-Phe, L-Dopa, His and D-His; or

a valine (V) substituted with an amino acid selected from the group consisting of D-Val, Leu, D-Leu, Ile, D-Ile, Met, D-Met, AdaA and AdaG.

5. The polypeptide of claim 1 , wherein the modified microbial rhodopsin comprises seven transmembrane domains.

6. The polypeptide of claim 1 , wherein the modified microbial rhodopsin comprises a protein core that binds a retinilydene chromophore.

7. The polypeptide of claim 1 , wherein the modified microbial rhodopsin comprises at least 96% sequence identity to SEQ ID NO: 1.

8. The polypeptide of claim 1 , wherein the modified microbial rhodopsin comprises at least 97% sequence identity to SEQ ID NO: 1.

9. The polypeptide of claim 1 , wherein the modified microbial rhodopsin comprises at least 98% sequence identity to SEQ ID NO: 1.

10. The polypeptide of claim 1 , wherein the modified microbial rhodopsin comprises, relative to SEQ ID NO: 1, at least a first substitution mutation selected from the group consisting of D95Q and D106H and a second substitution mutation selected from the group consisting of P60S, T80S, and F161V.

11. The polypeptide of claim 1 , wherein the sequence of the modified microbial rhodopsin is SEQ ID NO: 2.

12. The polypeptide of claim 1 , wherein the sequence of the modified microbial rhodopsin is SEQ ID NO: 3.

13. The polypeptide of claim 1 , wherein the sequence of the modified microbial rhodopsin comprises SEQ ID NO: 2.

14. The polypeptide of claim 1 , wherein the sequence of the modified microbial rhodopsin comprises SEQ ID NO: 3.

15. A polynucleotide encoding the polypeptide of claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2020
From: COHEN, ADAM E.; FARHI, SAMOUIL; HOCHBAUM, DANIEL R.; ZOU, PENG
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 053038/0783 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2020
From: CAMPBELL, ROBERT; HARRISON, DANIEL JED; ZHAO, YONGXIN
To: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
Reel/Frame 053039/0149 →
Continuity (4)
Continuation 15362594 · Nov 28, 2016
Continuation 14742648 · Jun 17, 2015
Provisional Application 62013775 · Jun 18, 2014
Related Publication 20200123218A1 · Apr 23, 2020